Incyte
INCY
#1039
Rank
A$32.71 B
Marketcap
A$161.41
Share price
0.04%
Change (1 day)
24.70%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of June 2026 : A$9.07 Billion

According to Incyte's latest financial reports the company has A$9.07 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$7.71 B39.19%
2024-12-31$A$5.54 B-27.24%
2023-12-31$A$7.61 B18.62%
2022-12-31$A$6.42 B23.49%
2021-12-31$A$5.20 B53.13%
2020-12-31$A$3.39 B-8.5%
2019-12-31$A$3.71 B35.75%
2018-12-31$A$2.73 B30.89%
2017-12-31$A$2.08 B258.92%
2016-12-31$A$0.58 B147.69%
2015-12-31$A$0.23 B-335.55%
2014-12-31$-A$99.75 Million-53.93%
2013-12-31$-A$0.22 Billion28.59%
2012-12-31$-A$0.17 Billion-23.98%
2011-12-31$-A$0.23 Billion153.78%
2010-12-31$-A$87.27 Million-23.43%
2009-12-31$-A$0.12 Billion-63.57%
2008-12-31$-A$0.32 Billion71.49%
2007-12-31$-A$0.19 Billion69.39%
2006-12-31$-A$0.11 Billion306.31%
2005-12-31$-A$26.51 Million-126.13%
2004-12-31$A$0.10 B-51.13%
2003-12-31$A$0.20 B-61.32%
2002-12-31$A$0.53 B-37.77%
2001-12-31$A$0.86 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
A$60.02 B 561.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$122.34 B 1,247.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.48 B 434.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.72 B 84.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.38 B-84.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.31 B-96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$36.28 Million-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
A$41.28 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.21 B-97.65%๐Ÿ‡บ๐Ÿ‡ธ USA